• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Less than 2% of U.S. Blood Donations Positive for SARS-CoV-2 Antibodies

September 22, 2020

In order to gain a better understanding of SARS-CoV-2 seroprevalence, the American Red Cross tested all blood donations from June 15, 2020 to August 23, 2020 for anti-SARS-CoV-2 IgG.  Of the 953,926 donations collected, 17,336 (1.82%) were positive for SARS-CoV-2 antibodies.  Almost 3% (N=4786) of first-time donors were seropositive compared to 1.58% (N=12,550) of repeat donors.  Donors age 18-24 years (3.87%) were more likely to be seropositive compared to those age 55 years or older (1.30%) (P<0.001).  Both African American (4.11%) and Hispanic donors (4.35%) were more likely to have antibodies compared to white donors (1.65%) (P<0.001 for both comparisons).  In addition, seroprevalence in donations increased from 1.18% in June to 2.58% in August 2020, and seroprevalence increased over time across all regions except the Northeast.  Seroprevalence estimates from this population may not reflect the true underlying proportion exposed to SARS-CoV-2 in the United States.  Furthermore, American Red Cross donation centers are underrepresented in some areas in the U.S. including New York City and south Florida.  Nevertheless, screening blood donors for SARS-CoV-2 antibodies may help monitor trends of the infection.

Reference:

  1. Dodd RY, Xu M, Stramer SL. Change in donor characteristics and antibodies to SARS-CoV-2 in donated blood in the US June-August 2020. JAMA

Filed Under

  • Blood Donation
  • News
  • Transfusion Transmitted Infections

Recommended

  • AABB and the CDC Outline Guidelines for Laboratory Testing of Patients with Suspected Ebola

  • Evaluation of PrEP/PEP Deferrals and U.S. House of Representatives Question MSM Deferral Policy for Blood Donors

  • Large-Scale Production of Red Blood Cells from Peripheral Blood Mononuclear Cells

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

  • Prothrombin Complex Concentrate Is Safe and Effective for Cardiac Surgery Patients with Coagulopathic Bleeding

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley